Home / Research library / Melanotan-2
Melanotan-2: molecular data, studies & sources
Melanotan-2 is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
- Molecular formula (MF)
- C50H69N15O9
- Molecular weight (MW)
- 1024.2 g/mol
- PubChem compound ID
- 92432
- Record title
- melanotan-II
Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.
Source: PubChem CID 92432 · retrieved 2026-09-21

Chemical identifiers and source data
- IUPAC name
- (3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxamide
- InChIKey
- JDKLPDJLXHXHNV-MFVUMRCOSA-N
- SMILES
- CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)N)NC(=O)C
Identifiers & sequence
- PubChem CID
- 92432
- CAS Registry Number
- 121062-08-6via ChemIDplus, EPA DSSTox, FDA GSRS
- FDA UNII
- UPF5CJ93X7
- ChEMBL ID
- CHEMBL430239
- InChIKey
- JDKLPDJLXHXHNV-MFVUMRCOSA-N
- Wikidata
- Q423855
Peptide sequence · 7 residues (one-letter code; X marks a residue without a one-letter code)
XDHFRWK
Condensed notation with terminal groups and non-standard residues
Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp-Lys(1)-NH2
Source: PubChem Biologic Line Notation. A reference sequence for the record, not an analysis of a supplied batch.
CAS numbers are published only from ChemIDplus, EPA DSSTox or the FDA Global Substance Registration System; UNII codes are confirmed in FDA GSRS by structure, sequence or exact name. Checked 2026-10-07.
Calculated molecular descriptors
| Monoisotopic (exact) mass | 1023.5403 Da |
|---|---|
| Heavy atoms | 74 |
| Hydrogen-bond donors | 13 |
| Hydrogen-bond acceptors | 11 |
| Rotatable bonds | 17 |
| Topological polar surface area | 384.8 Ų |
| Calculated logP (Crippen) | -1.25 |
| Rings | 5 |
| Stereocenters | 7 |
| Formal charge | 0 |
Computed with RDKit from the published SMILES (Crippen logP, topological polar surface area). Calculated descriptors are not measured properties of a supplied batch.
Registered clinical trials
Studies registered on ClinicalTrials.gov that list Melanotan-2 as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.
1 registered study matched, 1 currently active or recruiting.
- By highest phase
- Phase 2 · 1
- By registry status
- Recruiting · 1
| Study | Phase · status | Conditions | Sponsor · size |
|---|---|---|---|
| Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental VitiligoNCT07437560 · start 2026-02-02 · primary completion 2027-02-14 | Phase 2Recruiting | NonSegmental Vitiligo · Nonsegmental Vitiligo (Stable) | Hudson Biotech60 participants |
Registry check 2026-10-09 · Run this search on ClinicalTrials.gov
Human intervention studies
Selected studies in which participants received Melanotan-2, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.
- Human study · PubMed trial index Compound given to participants
Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study.
Dorr RT, Lines R, Levine N et al. · Life sciences · 1996
PMID 8637402 · DOI: 10.1016/0024-3205(96)00160-9
- Human study · PubMed trial index Compound given to participants
Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II.
Wessells H, Levine N, Hadley ME et al. · International journal of impotence research · 2000
PMID 11035391 · DOI: 10.1038/sj.ijir.3900582
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
- Review · secondary evidence
Melanotan II: a possible cause of renal infarction: review of the literature and case report.
Peters B, Hadimeri H, Wahlberg R et al. · CEN case reports · 2020
PMID 31953620 · DOI: 10.1007/s13730-020-00447-z
Melanotan-2 supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
Melanotan-2 for sale: compare prices, sizes and forms from every tracked supplier →
Reference sources & further reading
- PubChem compound record 92432 — chemical identity and structure.
- FDA Global Substance Registration System: UNII UPF5CJ93X7 — substance identity, names and codes.
- Wikipedia: Melanotan II — Background encyclopedia; not a primary clinical source.
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
Acetyl Hexapeptide-3 (Argireline)
C35H62N14O11S
887.0 g/mol · PubChem CID 71587772
6 selected publications · 1 human intervention study · 3 registered trials
AHK-Cu
Molecular identity needs further verification
1 selected publication · 0 human intervention studies
Decapeptide-12
Molecular identity needs further verification
3 selected publications · 2 human intervention studies
GHK Basic (Tripeptide-1)
Molecular identity needs further verification
5 selected publications · 0 human intervention studies
Kisspeptin-10
C63H83N17O14
1302.4 g/mol · PubChem CID 25240297
5 selected publications · 3 human intervention studies · 5 registered trials
Protein / peptide · highest stage: Phase 3
Lipopeptide (Biopeptide EL)
Molecular identity needs further verification
Source verification pending
0 selected publications · 0 human intervention studies